On the recordJune 28, 2000
U.S. consumers are paying a premium for their prescription drugs. It is wrong. U.S. consumers have no problem paying for the product that they consume. They have no problem paying for the research and development costs that the companies incur. They do not mind paying a fair return to the investor and the drug companies. What they do object to is paying the profits and the research and development costs of our colleagues and our neighbors in Mexico, in Canada, in other parts of the world. We are subsidizing the consumption of prescription drugs in Canada, Mexico, and Europe. It is not fair to the American consumer, it is not fair to our American taxpayer. What this bill does is it says that if our consumers find these drugs, prescription drugs, available at a lower price in Canada, Mexico, or somewhere else, these drugs, prescription drugs, will be made available to the American consumer. It is the fair thing and it is the right thing to do.
Source
govinfo.gov




